| Literature DB >> 34170503 |
Wen-Liang Song1, Ning Zou1, Wen-He Guan1, Jia-Li Pan1, Wei Xu2.
Abstract
BACKGROUND: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread around the world and reports of children during early epidemic period showed features of family clusters. The aim of this study is to assess clinical profiles of COVID-19 in family clusters with children.Entities:
Keywords: Children; Coronavirus disease 2019; Family clusters; Severe acute respiratory syndrome coronavirus 2
Mesh:
Year: 2021 PMID: 34170503 PMCID: PMC8229253 DOI: 10.1007/s12519-021-00434-z
Source DB: PubMed Journal: World J Pediatr Impact factor: 9.186
Fig. 1Flow diagram of the study selection process
General clinical characteristics of children and adults in family clusters of coronavirus disease 2019
| Variables | Children ( | Adults ( | ||
|---|---|---|---|---|
| Sex, | 0.338 | 0.561 | ||
| Male | 14 (41.2) | 46 (46.9) | ||
| Female | 20 (46.9) | 52 (53.1) | ||
| Age, median (IQR) | 4 y 3 mon (2 mon-10 y) | 18–83 y | ||
| Incubation period (d), median (IQR) | 10 (1–30) ( | 7 (1–29) ( | -2.001 ( | 0.045 |
| Duration of pharyngeal swab NAT-positive period (d), median (IQR) | 11 (6–27) ( | 17 (3 to > 37) ( | -2.373 ( | 0.018 |
| Clinical manifestation, | ||||
| Number of asymptomatic infection | 11 (32.4) | 13 (13.3) | 6.182 | 0.013 |
| Fever | 15 (44.1) | 61 (62.2) | 3.396 | 0.065 |
| Body temperature grading | 0.033 | 0.855 | ||
| Low-grade fever | 3 (33.3) ( | 9 (45.0) ( | ||
| Moderate fever | 6 (66.7) ( | 11 (55.0) ( | ||
| Cough | 6 (17.6) | 44 (44.9) | 7.966 | 0.005 |
| Fatigue | 3 (8.8) | 24 (24.5) | 3.808 | 0.051 |
| Myalgia | 0 (0.0) | 11 (11.2) | 2.824 | 0.093 |
| Sore throat | 1 (2.9) | 10 (10.2) | 0.922 | 0.337 |
| Chest pain | 0 (0.0) | 5 (5.1) | 0.675 | 0.411 |
| Polypnea | 0 (0.0) | 3 (3.1) | 0.569 | |
| Dyspnea | 0 (0.0) | 2 (2.0) | 1.000 | |
| Chest tightness | 0 (0.0) | 4 (4.1) | 0.379 | 0.538 |
| Rhiborrhea | 1 (2.9) | 3 (3.1) | 0.000 | 1.000 |
| Sneezing | 0 (0.0) | 1 (1.0) | 1.000 | |
| Vomiting | 2 (5.9) | 0 (0.0) | 0.065 | |
| Diarrhea | 4 (11.8) | 2 (2.0) | 3.488 | 0.062 |
IQR interquartile range, NAT nucleic acid test
Blood routine test characteristics of children and adults in family clusters of coronavirus disease 2019
| Laboratory examinations | Children | Adults | |||||
|---|---|---|---|---|---|---|---|
| WBC (× 109/L), median (IQR) | 6.68 (2.23–11.7) ( | 1.75–11.40 ( | |||||
| WBC decreased, | 6 (18.2) ( | 14 (14.4) ( | 0.130 | 0.718 | |||
| WBC normal, | 27 (81.8) ( | 83 (85.6) ( | |||||
| Lymphocyte (× 109/L), median (IQR) | 4.52 (1.25–9.06) | 0.29–6.23 | |||||
| Lymphocyte decreased, | 1 (3.0) ( | 41 (42.3) ( | 17.334 | < 0.001 | |||
| Lymphocyte normal, | 30 (90.9) ( | 54 (55.7) ( | 13.373 | < 0.001 | |||
| Lymphocyte increased, | 2 (6.1) ( | 2 (2.1) ( | 0.320 | 0.572 | |||
| CRP (mg/L) | 0–12.6 | 0.5–150.0 | |||||
| CRP normal, | 29 (96.7) ( | 41 (63.1) ( | 11.944 | 0.001 | |||
| PT(s) | 10.5–13.1 | 10.0–14.4 | |||||
| PT normal, | 6 (100) ( | 20 (100) ( | |||||
| APTT(s) | 34.0–42.9 | 25.8–49.6 | |||||
| APTT normal, | 7 (100) ( | 17 (65.4) ( | 3.332 | 0.068 | |||
| 0.10–0.43 | 0.19–0.71 | ||||||
| 10 (100) ( | 16 (88.9) ( | 1.197 | 0.274 | ||||
| ALT(U/L) | 9.0–23.9 | 10.8–36.0 | |||||
| ALT normal, | 17 (100) ( | 26 (100) ( | |||||
| AST(U/L) | 23.0–42.0 | 18.1–40.2 | |||||
| AST normal, | 12 (100) ( | 21 (100) ( | |||||
| CK(U/L) | 78–131 | 176–301 | |||||
| CK normal, | 10 (100) ( | 25 (71.4) ( | 2.433 | 0.119 | |||
IQR interquartile range, WBC white blood cell, CRP C-reactive protein, PT prothrombin time, APTT activated partial thromboplastin time, ALT alanine aminotransferase, AST aspartate aminotransferase, CK creatine kinase
Chest computed tomography manifestations of children and adults in family clusters of coronavirus disease 2019
| Chest CT | Children | Adults | ||
|---|---|---|---|---|
| Normal, | 16 (55.2) ( | 17 (18.9) ( | 14.408 | < 0.001 |
| Abnormal, | 13 (44.8) ( | 73 (81.1) ( | ||
| GGO, | 9 (69.2) ( | 38 (52.0) ( | 1.314 | 0.252 |
| Pneumonia, | 2 (15.4) ( | 20 (27.4) ( | 0.324 | 0.569 |
| Consolidation, | 2 (15.4) ( | 14 (19.2) ( | 0.000 | 1.000 |
| Patchy, | 2 (15.4) ( | 8 (11.0) ( | 0.000 | 1.000 |
| Nodular, | 0 (0.0) ( | 8 (11.0) ( | 0.540 | 0.462 |
| Bronchitis, | 2 (15.4) ( | 1 (1.4) ( | 0.058 | |
CT computed tomography, GGO ground-grass opacity